- Filed
- Jun 4, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2027 · May 28, 2026 | 254.56M sh |
| Shares Diluted | Q1 2027 · Apr 30, 2026 | 257.88M sh |
| Shares Diluted | Q1 2027 · Apr 30, 2025 | 248.43M sh |
| Stock Repurchased | Q1 2027 · Apr 30, 2026 | $175.62M |
| Stock Repurchased | Q1 2027 · Apr 30, 2025 | $0 |
| Capex | Q1 2027 · Apr 30, 2026 | $97.62M |
| Capex | Q1 2027 · Apr 30, 2025 | $85.75M |
| Operating Cash Flow | Q1 2027 · Apr 30, 2026 | $590.94M |
| Operating Cash Flow | Q1 2027 · Apr 30, 2025 | $384.11M |
| Long Term Debt | Q1 2027 · Apr 30, 2026 | $745.84M |
| Long Term Debt | Q1 2027 · Jan 31, 2026 | $745.47M |
| Cash And Equivalents | Q1 2027 · Apr 30, 2026 | $4.55B |
| Cash And Equivalents | Q1 2027 · Jan 31, 2026 | $5.23B |
| Cash And Equivalents | Q1 2027 · Apr 30, 2025 | $4.61B |
| Stockholders Equity | Q1 2027 · Apr 30, 2026 | $4.63B |
| Stockholders Equity | Q1 2027 · Jan 31, 2026 | $4.43B |
| Current Liabilities | Q1 2027 · Apr 30, 2026 | $4.12B |
| Current Liabilities | Q1 2027 · Jan 31, 2026 | $4.18B |
| Total Liabilities | Q1 2027 · Apr 30, 2026 | $6.59B |
| Total Liabilities | Q1 2027 · Jan 31, 2026 | $6.61B |
| Current Assets | Q1 2027 · Apr 30, 2026 | $6.3B |
| Current Assets | Q1 2027 · Jan 31, 2026 | $7.42B |
| Total Assets | Q1 2027 · Apr 30, 2026 | $11.27B |
| Total Assets | Q1 2027 · Jan 31, 2026 | $11.09B |
| Eps Diluted | Q1 2027 · Apr 30, 2026 | $0.11 |
| Eps Diluted restated | Q1 2027 · Apr 30, 2025 | −$0.42 |
| Eps Basic | Q1 2027 · Apr 30, 2026 | $0.11 |
| Eps Basic restated | Q1 2027 · Apr 30, 2025 | −$0.42 |
| Sga Expense | Q1 2027 · Apr 30, 2026 | $176.95M |
| Sga Expense restated | Q1 2027 · Apr 30, 2025 | $164.14M |
| Rd Expense | Q1 2027 · Apr 30, 2026 | $408.33M |
| Rd Expense restated | Q1 2027 · Apr 30, 2025 | $330.93M |
| Net Income | Q1 2027 · Apr 30, 2026 | $27.77M |
| Net Income restated | Q1 2027 · Apr 30, 2025 | −$104.26M |
| Operating Income | Q1 2027 · Apr 30, 2026 | −$30.6M |
| Operating Income restated | Q1 2027 · Apr 30, 2025 | −$118.71M |
| Gross Profit | Q1 2027 · Apr 30, 2026 | $1.04B |
| Gross Profit restated | Q1 2027 · Apr 30, 2025 | $815.56M |
| Cost Of Revenue | Q1 2027 · Apr 30, 2026 | $342.28M |
| Cost Of Revenue restated | Q1 2027 · Apr 30, 2025 | $287.88M |
| Revenue | Q1 2027 · Apr 30, 2026 | $1.39B |
| Revenue | Q1 2027 · Apr 30, 2025 | $1.1B |